Patient-reported treatment burden, communication, and persistence intention during add-on peginterferon alfa-2b therapy for chronic hepatitis B: a cross-sectional study.
Ning Han, Huan Liu, Libo Yan et al.Frontiers in public health
BACKGROUND: Add-on peginterferon alfa-2b (Peg-IFN) may help reduce hepatitis B surface antigen levels and achieve a functional cure in selected patients with chronic hepatitis B (CHB), but the treatment burden can make a finite course difficult to complete. We examined the patient-reported factors…
